PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Competition Looming!, page-2

  1. 253 Posts.
    lightbulb Created with Sketch. 33
    it’s called Diacerin and is currently not permitted for use in Australia.
    It hasn’t even reached phase I trials yet and it’s classified as an anti inflammatory. Not disease modifying.

    No worries here, just noise in the media
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.